Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

PreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International Operations

GlobeNewswire February 26, 2018

NetworkNewsAudio Announces Audio Press Release (APR) on PreveCeutical Medical Inc.Transforming Industry with Cannabinoid Delivery Advancements

Newsfile February 23, 2018

NetworkNewsWire Announces Publication on Unique New Paradigms in Cannabinoid Drug Delivery

GlobeNewswire February 22, 2018

NetworkNewsAudio Announces Audio Press Release (APR) on Drug Delivery Advancements Bring Attractive Investment Opportunities

Newsfile February 9, 2018

NetworkNewsWire Announces Publication on Innovators in New Drug Delivery Systems

GlobeNewswire February 8, 2018

PreveCeutical Medical Inc. (PRVCF) Engages NetworkNewsWire for Corporate Communications Solutions

GlobeNewswire February 6, 2018

NetworkNewsAudio Announces Audio Press Release (APR) on Exciting New Solutions to Tackle Pain

Newsfile February 5, 2018

NetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive Analgesics

GlobeNewswire February 2, 2018

PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides

GlobeNewswire January 30, 2018

NetworkNewsAudio Announces Audio Press Release (APR) on the Cannabis Industry Driving Medical Therapy R&D

Newsfile January 29, 2018

NetworkNewsWire Announces Publication on Advancements in Cannabis Industry Biotech Therapy

GlobeNewswire January 26, 2018

PreveCeutical releases update on scorpion venom research

Stockhouse Editorial January 24, 2018

PreveCeutical Provides Update on Scorpion Venom-Derived Peptide Program

Newsfile January 24, 2018

PreveCeutical Medical Inc. Now Accepts Bitcoin as a Payment Method

Newsfile January 15, 2018

PreveCeutical Medical Inc. Receives Coverage from Crystal Equity Research

GlobeNewswire January 11, 2018

PreveCeutical Announces Amendment to $3.28 Million Non-Brokered Private Placement

Newsfile January 3, 2018

PreveCeutical Medical Inc. Announces $3.28 Million Fully Subscribed Private Placement

Newsfile November 22, 2017

PreveCeutical Receives Australian State Approval to Acquire and Use Cannabis as Part of Its Research and Development Program

Newsfile November 1, 2017

PreveCeutical Medical Inc. Announces Appointment of Dr. Makarand Jawadekar to its Board of Directors

Newsfile October 26, 2017

PreveCeutical Medical Inc. Announces Filing of Amended and Restated Interim Financial Statements

Newsfile October 23, 2017